Fountain Report Excerpts

See below for curated highlights from the most recent additions to the Fountain Report.

The Fountain Report is a weekly subscription service provided by Antelligence. Its comprehensive in-depth news and quantitative data have been guiding decision making for executives in the business of animal health since 2002.

Click HERE to subscribe to the full Fountain Report content.

Fountain Report Excerpts Feb 20, 2024

Zoetis reported fourth quarter revenue of $2.2 billion, up 8%. Net income of $525 million, or $1.14 per diluted share, was up 14% (15% per share). For the year, revenue of $8.5 billion was up 6%. Net income of $2.3 billion, or $5.07 per diluted share, was up 11% (13% per share). Quarterly highlights included an [...]
Read More

Fountain Report Excerpts Feb 13, 2024

Elanco Animal Health has agreed to sell its aqua business to Merck Animal Health for approximately $1.3 billion in cash, representing approximately 7.4 times the estimated 2023 revenue of the Elanco aqua business, according to the announcement. The transaction reinforces Elanco’s focus on its most significant value creation opportunities, notably in pet health and livestock sustainability. [...]
Read More

Fountain Report Excerpts Feb 6, 2024

The American Association of Veterinary Medical Colleges announced it has recently welcomed 12 new institutions for membership. The Universidad de Ana G. Mendez in Puerto Rico has received a letter of reasonable assurance from the Council on Education and was welcomed as a member institution of the AAVMC. Provisional membership is available for a school of [...]
Read More

Fountain Report Excerpts Jan 30, 2024

Vetoquinol reported 2023 sales of 529 million euros, stable at constant exchange rates and down 1.9% on a reported basis. At the end of December, sales of Essentials products totaled 313 million euros, up 4.5% at constant exchange rates and 2.9% on a reported basis. Companion animal product sales of 372 million euros were up [...]
Read More

Fountain Report Excerpts Jan 23, 2024

Virbac reported fourth quarter 2023 revenue of 321.7 million euros, up 9.1% from the same period in 2022. For the year, revenue of 1.25 billion euros was up 2.5% and up 4.9% at constant exchange rates. In terms of species, despite a drop in sales on dog and cat vaccine range (which was out of [...]
Read More